News

Studies leading up to the FDA approval found that people with hand eczema who used the cream were more likely to improve than ...
New data highlight efficacy, safety, and time off treatment with as-needed ruxolitinib cream in pediatric atopic dermatitis.
Incyte Corporation (NASDAQ:INCY) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 15, ...
Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...
The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
The Greenwich Department of Health is issuing a warning about cases of “swimmer’s itch” at Greenwich Point beach. The ...
The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...
The Greenwich Department of Health is issuing a warning about cases of “swimmer’s itch” at Greenwich Point beach. The ...
Sara Sampaio shares her wellness rituals, minimalist beauty routine and the transformation to take on the role of ‘Superman’ ...
AESTURA, Korea’s #1 dermatologist-recommended dermocosmetic brand for sensitive skin[1] breaks new ground in the Canadian skincare market with its exclusive launch ...
Cut to everyone thinking you own a pair of Miu Miu sunglasses and a rainbow of Lululemon Align tops when you secretly bought ...